Companies /Healthcare

Evolent Health Inc - Class A

NYSE: EVH Health Information Services
$4.24
▲ $0.20 (+4.95%) today
Markets closed · 5:54pm ET

24/7 Wall St. View

EVH at a Glance

Valuation
Market cap
$456.8M
Profitability
Revenue (TTM)
$2.1B
Profit margin
-24.1%
EPS (TTM)
$-4.49
Price
52-week range
$2 – $8
24/7 target
$6.06
Street target
$5.75
Earnings
Next report
Nov 5, 2026
Q2 2026 EPS
$0.02
vs. $-0.02 est.
+229.9%

Headquartered in Arlington, VA Fiscal year ends December NYSE: EVH evolent.com

About Evolent Health

Evolent Health, Inc. (NYSE: EVH) is a healthcare technology and services company that specializes in improving health outcomes for people with complex conditions through solutions that simplify and reduce the cost of specialty care management. The company serves a national base of payers and providers through its Performance Suite (risk-bearing specialty care management covering oncology, cardiology, musculoskeletal, and advanced imaging), Specialty Technology and Services Suite (technology-enabled administrative and clinical support services), Administrative Services, and case-based programs including surgery management and advanced care planning. Evolent's business model centers on per-member-per-month fees and performance-based arrangements with health plans. The company sold its Evolent Care Partners subsidiary in December 2025 and is increasingly focused on AI-driven operational models to enhance clinical outcomes and cost discipline. Updated

Revenue by Segment · Q2 2026
  1. Performance Suite74%
  2. Specialty Technology and Services Suite12%
  3. Administrative Services7%
  4. Cases6%

EVH Coverage

8:19pm ET
Investing

Agentic AI Powers U.S. Healthcare Stocks

Healthcare payrolls keep climbing, and hospital systems, payers, and clinics are now openly treating agentic AI as the cheapest unit of labor on the market. Stocks trading under $20 with credible agentic…

Alex Sirois

Frequently Asked Questions

What does Evolent Health do?

Evolent Health, Inc. (NYSE: EVH) is a healthcare technology and services company that specializes in improving health outcomes for people with complex conditions through solutions that simplify and reduce the cost of specialty care management.

What is the EVH stock price target?

24/7 Wall St.'s 12-month price target for EVH is $6.06, rated Buy. The Wall Street consensus target is $5.75. EVH price prediction →